GRAFT VERSUS HOST DISEASE, ACUTE
Clinical trials for GRAFT VERSUS HOST DISEASE, ACUTE explained in plain language.
Never miss a new study
Get alerted when new GRAFT VERSUS HOST DISEASE, ACUTE trials appear
Sign up with your email to follow new studies for GRAFT VERSUS HOST DISEASE, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop pills may shield bone marrow patients from deadly immune attack
Disease control Recruiting nowThis study tests whether giving patients their own healthy gut bacteria (via a fecal transplant) can prevent acute graft-versus-host disease, a serious complication where donor immune cells attack the patient's body after a stem cell transplant. About 100 people receiving a half-…
Matched conditions: GRAFT VERSUS HOST DISEASE, ACUTE
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New cell therapy shows promise for deadly transplant complication
Disease control Recruiting nowThis study tests an experimental treatment called CYP-001 for people who develop a serious complication called graft-versus-host disease after a stem cell transplant. The treatment is given alongside standard steroids to see if it helps control the disease better than steroids al…
Matched conditions: GRAFT VERSUS HOST DISEASE, ACUTE
Phase: PHASE2 • Sponsor: Cynata Therapeutics Limited • Aim: Disease control
Last updated May 12, 2026 13:41 UTC